BioPharmX Corp (BPMX)

BioPharmX's (BPMX) Q1 2018 Results - Earnings Call Transcript
June 13, 2017 | Price: Free! | Source: Seeking Alpha

BioPharmX's (BPMX) Q4 2017 Results - Earnings Call Transcript
March 23, 2017 | Price: Free! | Source: Seeking Alpha

BioPharmX (BPMX) Q3 2017 Results - Earnings Call Transcript
Dec. 13, 2016 | Price: Free! | Source: Seeking Alpha

BioPharmX (BPMX) Q2 2016 Results - Earnings Call Transcript
Sept. 13, 2016 | Price: Free! | Source: Seeking Alpha

BioPharmX (BPMX) Q1 2016 Results - Earnings Call Transcript
June 14, 2016 | Price: Free! | Source: Seeking Alpha

BioPharmX's (BPMX) CEO Jim Pekarsky on Q1 2016 Results - Earnings Call Transcript
April 26, 2016 | Price: Free! | Source: Seeking Alpha

Recent filings

Changes in Registrants Certifying - July 2, 2020

Securities to be offered to employees in employee benefit plans - June 16, 2020

BioPharmX Corp Just Filed Its Quarterly Report: Net Loss per Shar... - June 12, 2020

BioPharmX Corp director was just granted 24,270 options - June 9, 2020

BioPharmX Corp director was just granted 24,270 options - June 9, 2020

BioPharmX Corp's Controller was just granted 38,833 options - June 9, 2020

BioPharmX Corp's Controller just declared ownership of no shares of BioPharmX Corp - June 9, 2020

BioPharmX Corp director was just granted 24,270 options - June 9, 2020

BioPharmX Corp director was just granted 24,270 options - June 9, 2020

BioPharmX Corp's Executive VP & CFO was just granted 97,083 options - June 9, 2020

Entry into a Material Definitive - June 3, 2020

Statement of acquisition of beneficial ownership by individuals - May 29, 2020

Timber Pharmaceuticals LLC just provided an update on activist position in BioPharmX Corp - May 28, 2020

Martin D. Hoe just provided an update on share ownership of BioPharmX Corp - May 27, 2020

BioPharmX: Timber Pharmaceuticals Announces Merger Closing - May 22, 2020

Executive VP of BioPharmX Corp just declared ownership of no shares of BioPharmX Corp - May 20, 2020

Executive VP of BioPharmX Corp was just granted 132,209 ownership of the company. - May 20, 2020

BioPharmX Corp director just declared ownership of no shares of BioPharmX Corp - May 20, 2020

BioPharmX Corp's Chief Executive Officer just declared ownership of no shares of BioPharmX Corp - May 20, 2020

BioPharmX Corp's Executive Chairman just declared ownership of no shares of BioPharmX Corp - May 20, 2020

BioPharmX Corp director just declared ownership of no shares of BioPharmX Corp - May 20, 2020

BioPharmX Corp director just declared ownership of no shares of BioPharmX Corp - May 20, 2020

BioPharmX Corp's Executive VP & CFO just declared ownership of no shares of BioPharmX Corp - May 20, 2020

Major owner of BioPharmX Corp just picked up 5,666,152 shares - May 20, 2020

BioPharmX Corp insider just declared ownership of no shares of BioPharmX Corp - May 20, 2020

BioPharmX Corp's Chief Scientific Officer just declared ownership of no shares of BioPharmX Corp - May 20, 2020

BioPharmX Corp director just declared ownership of no shares of BioPharmX Corp - May 20, 2020

BioPharmX Corp's Chief Scientific Officer was just granted 8,184 ownership of the company. - May 20, 2020

BioPharmX Corp's Chief Executive Officer was just granted 209,646 ownership of the company. - May 20, 2020

Biopharmx Announces 1-For-12 Reverse Stock Split - May 15, 2020

Prospectuses and communications, business combinations - May 13, 2020

Biopharmx Corporation Announces Approval Of Merger By Stockholders At Special Meeting - May 13, 2020

Prospectuses and communications, business combinations - May 11, 2020

Timber Pharmaceuticals LLC - May 11, 2020

Prospectuses and communications, business combinations - May 7, 2020

Prospectuses and communications, business combinations - April 27, 2020

Biopharmx Corporation Announces That Its Special StockholdersÂ’ Meeting - April 27, 2020

BioPharmX: Form, Schedule Or Registration Statement No Filing Party: Date Filed: BIOPHARMX CORPORATION - April 27, 2020

Prospectuses and communications, business combinations - April 6, 2020

BioPharmX: Bpmx Exh 99.1_Timber Tmb001 - April 6, 2020

BioPharmX Corp just filed a prospectus, suggesting it plans to soon issue some securities - April 1, 2020

BioPharmX Corp Just Received a Notice of Effectiveness - March 31, 2020

Registration of securities, business combinations - March 30, 2020

Prospectuses and communications, business combinations - March 30, 2020

BioPharmX: Bpmx Exh 99.1 Nyse Delisting Notice - March 30, 2020

BioPharmX Corp Just Filed Its Annual Report: Net Loss Per Shar... - March 23, 2020

Registration of securities, business combinations - Feb. 20, 2020

Entry into a Material Definitive - Feb. 18, 2020

Vivo Capital VIII, LLC just provided an update on share ownership of BioPharmX Corp - Feb. 13, 2020

Major owner of BioPharmX Corp just picked up 2,200,328 shares - Feb. 12, 2020

Major owner of BioPharmX Corp just picked up 2,200,328 shares - Feb. 12, 2020

Departure of Directors or Certain - Feb. 3, 2020

Major owner of BioPharmX Corp just declared 0 ownership of the company. - Jan. 30, 2020

TardiMed Sciences LLC just provided an update on activist position in BioPharmX Corp - Jan. 30, 2020

Major owner of BioPharmX Corp just declared 0 ownership of the company. - Jan. 30, 2020

BioPharmX: Bpmx Exh Merger_99.1 Press Release - Jan. 29, 2020

Prospectuses and communications, business combinations - Jan. 29, 2020

Martin D. Hoe just provided an update on share ownership of BioPharmX Corp - Jan. 15, 2020

Biopharmx Reports Fiscal Third Quarter 2020 Financial Results And Provides Corporate Update - Dec. 10, 2019

BioPharmX Corp Just Filed Its Quarterly Report: Net Loss per Shar... - Dec. 10, 2019

Biopharmx Receives Notice Of Compliance Deadline Extension From Nyse American - Sept. 20, 2019

Biopharmx Reports Fiscal Second Quarter 2020 Financial Results And Provides Corporate Update - Sept. 9, 2019

BioPharmX Corp Just Filed Its Quarterly Report: Net Loss per Shar... - Sept. 9, 2019

BioPharmX Corp's Chief Operating Officer was just granted 91,000 options - July 18, 2019

BioPharmX Corp's Chief Operating Officer just declared owning 0 shares of BioPharmX Corp - July 18, 2019

Biopharmx Announces Steven M. Bosacki Joins The Company As Chief Operating Officer - July 17, 2019

Submission of Matters to a Vote to Security - July 11, 2019

Major owner of BioPharmX Corp just disposed of 327,870 shares - June 27, 2019

Vivo Capital VIII, LLC just provided an update on share ownership of BioPharmX Corp - June 27, 2019

Biopharmx Announces Positive Topline Results From Phase 2B Trial Of Bpx-04 For Papulopustular Rosacea - June 25, 2019

BioPharmX Corp director was just granted 32,700 options - June 14, 2019

BioPharmX Corp's Pres and CEO was just granted 360,000 options - June 14, 2019

BioPharmX Corp director was just granted 32,700 options - June 14, 2019

BioPharmX Corp's EVP of R&D was just granted 77,100 options - June 14, 2019

BioPharmX Corp director was just granted 32,700 options - June 14, 2019

BioPharmX Corp insider was just granted 70,000 options - June 14, 2019

BioPharmX Corp Just Filed Its Quarterly Report: Net Loss per Shar... - June 11, 2019

Biopharmx Reports Fiscal First Quarter 2020 Financial Results - June 11, 2019

Other definitive proxy statements - May 22, 2019

Entry into a Material Definitive - May 16, 2019

BioPharmX Corp just filed a prospectus, suggesting it plans to soon issue some securities - May 16, 2019

Biopharmx Completes 1-For-25 Reverse Stock Split - April 26, 2019

On March - March 25, 2019

BioPharmX Corp just filed a prospectus, suggesting it plans to soon issue some securities - March 22, 2019

Biopharmx Announces $3.9 Million Offering - March 21, 2019

Biopharmx Reports Fourth Quarter And Full Year 2019 Financial Results - March 14, 2019

Biopharmx Receives Notice Of Compliance Deadline Extension From Nyse American - Feb. 27, 2019

BioPharmX Corp director just declared owning 0 shares of BioPharmX Corp - Feb. 21, 2019

BioPharmX Corp director was just granted 418,000 options - Feb. 21, 2019

Statement of acquisition of beneficial ownership by individuals - Feb. 14, 2019

BioPharmX Corp Just Received a Notice of Effectiveness - Feb. 13, 2019

Biopharmx Strengthens Board Of Directors With Appointment Of Industry Veteran Dr. R. Todd Plott - Feb. 4, 2019

Registration statement under Securities Act of 1933 - Jan. 31, 2019

Martin D. Hoe just provided an update on share ownership of BioPharmX Corp - Jan. 29, 2019

BioPharmX Corp director just disposed of 115,874 shares - Jan. 25, 2019

Biopharmx Receives Notice Of Noncompliance From Nyse American - Dec. 20, 2018

Franklin Advisers, Inc. just provided an update on activist position in BioPharmX Corp - Dec. 7, 2018

BioPharmX Corp Just Filed Its Quarterly Report: Net Loss per Shar... - Dec. 7, 2018

Entry into a Material Definitive - Nov. 21, 2018

Franklin Advisers, Inc. just provided an update on activist position in BioPharmX Corp - Nov. 2, 2018

Sorry, no schedule available for this company

Owner Shares% of PortfolioAs Of
1. Leonid Frenkel 1,184,371 N/A Dec. 31, 2015
2. DEUTSCHE BANK AG\ 549,973 N/A Dec. 31, 2018
3. DEUTSCHE BANK AG\ 549,973 N/A Dec. 31, 2018
4. DEUTSCHE BANK AG\ 549,973 N/A Dec. 31, 2018
5. DEUTSCHE BANK AG\ 549,973 N/A Dec. 31, 2018
6. DEUTSCHE BANK AG\ 549,973 N/A Dec. 31, 2018
7. DEUTSCHE BANK AG\ 549,973 N/A Dec. 31, 2018
8. DEUTSCHE BANK AG\ 549,973 N/A Dec. 31, 2018
9. DEUTSCHE BANK AG\ 549,973 N/A Dec. 31, 2018
10. KCG Holdings, Inc. 503,418 N/A June 30, 2017
11. NORTHERN TRUST CORP 92,518 N/A March 31, 2019
12. NORTHERN TRUST CORP 92,518 N/A June 30, 2018
13. NORTHERN TRUST CORP 92,518 N/A March 31, 2019
14. NORTHERN TRUST CORP 92,518 N/A March 31, 2019
15. NORTHERN TRUST CORP 92,518 N/A June 30, 2018
16. NORTHERN TRUST CORP 92,518 N/A June 30, 2018
17. NORTHERN TRUST CORP 92,518 N/A March 31, 2018
18. NORTHERN TRUST CORP 92,518 N/A March 31, 2019
19. NORTHERN TRUST CORP 92,518 N/A March 31, 2019
20. NORTHERN TRUST CORP 92,518 N/A March 31, 2019
21. NORTHERN TRUST CORP 92,518 N/A March 31, 2019
22. VANGUARD GROUP INC 78,120 N/A June 30, 2019
23. VANGUARD GROUP INC 74,852 N/A Sept. 30, 2019
24. VANGUARD GROUP INC 74,852 N/A Sept. 30, 2019
25. VANGUARD GROUP INC 74,852 N/A Sept. 30, 2019
26. VANGUARD GROUP INC 74,852 N/A Dec. 31, 2019
27. VANGUARD GROUP INC 74,852 N/A March 31, 2020
28. VANGUARD GROUP INC 74,852 N/A March 31, 2020
29. VANGUARD GROUP INC 74,852 N/A March 31, 2020
30. LADENBURG THALMANN FINANCIAL SERVICES INC 64,200 N/A June 30, 2018

BioPharmX Corp (BPMX)

140

cctranscripts

yesterday

Changes in Registrants Certifying http://www.conferencecalltranscripts.org/pink/summary?id=8097955

cctranscripts

June 16, 2020

Securities to be offered to employees in employee benefit plans http://www.conferencecalltranscripts.org/pink/summary?id=8033884

cctranscripts

June 12, 2020

BioPharmX Corp Just Filed Its Quarterly Report: Net Loss per Shar... http://www.conferencecalltranscripts.org/pink/summary?id=8021190

cctranscripts

June 9, 2020

BioPharmX Corp's Executive VP & CFO was just granted 97,083 options http://www.conferencecalltranscripts.org/pink/summary?id=8005719

cctranscripts

June 9, 2020

BioPharmX Corp director was just granted 24,270 options http://www.conferencecalltranscripts.org/pink/summary?id=8005740

cctranscripts

June 9, 2020

BioPharmX Corp director was just granted 24,270 options http://www.conferencecalltranscripts.org/pink/summary?id=8005716

cctranscripts

June 9, 2020

BioPharmX Corp's Controller was just granted 38,833 options http://www.conferencecalltranscripts.org/pink/summary?id=8005697

cctranscripts

June 9, 2020

BioPharmX Corp director was just granted 24,270 options http://www.conferencecalltranscripts.org/pink/summary?id=8005763

cctranscripts

June 9, 2020

BioPharmX Corp director was just granted 24,270 options http://www.conferencecalltranscripts.org/pink/summary?id=8005707

cctranscripts

June 9, 2020

BioPharmX Corp's Controller just declared ownership of no shares of BioPharmX Corp http://www.conferencecalltranscripts.org/pink/summary?id=8005692

cctranscripts

June 3, 2020

Entry into a Material Definitive http://www.conferencecalltranscripts.org/pink/summary?id=7983153

cctranscripts

May 29, 2020

Statement of acquisition of beneficial ownership by individuals http://www.conferencecalltranscripts.org/pink/summary?id=7962129

cctranscripts

May 28, 2020

Timber Pharmaceuticals LLC just provided an update on activist position in BioPharmX Corp http://www.conferencecalltranscripts.org/pink/summary?id=7958306

cctranscripts

May 27, 2020

Martin D. Hoe just provided an update on share ownership of BioPharmX Corp http://www.conferencecalltranscripts.org/pink/summary?id=7951572

cctranscripts

May 22, 2020

BioPharmX: Timber Pharmaceuticals Announces Merger Closing http://www.conferencecalltranscripts.org/pink/summary?id=7936475

cctranscripts

May 20, 2020

Major owner of BioPharmX Corp just picked up 5,666,152 shares http://www.conferencecalltranscripts.org/pink/summary?id=7924599

cctranscripts

May 20, 2020

BioPharmX Corp director just declared ownership of no shares of BioPharmX Corp http://www.conferencecalltranscripts.org/pink/summary?id=7924638

cctranscripts

May 20, 2020

BioPharmX Corp's Chief Executive Officer was just granted 209,646 ownership of the company. http://www.conferencecalltranscripts.org/pink/summary?id=7924715

cctranscripts

May 20, 2020

BioPharmX Corp's Chief Scientific Officer was just granted 8,184 ownership of the company. http://www.conferencecalltranscripts.org/pink/summary?id=7924707

cctranscripts

May 20, 2020

Executive VP of BioPharmX Corp was just granted 132,209 ownership of the company. http://www.conferencecalltranscripts.org/pink/summary?id=7924719
 


Feedback